|
1
|
Replicon typing of plasmids encoding resistance to newer beta-lactams.
|
Emerg Infect Dis
|
2006
|
3.75
|
|
2
|
Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues.
|
Int J Antimicrob Agents
|
2007
|
2.61
|
|
3
|
Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems.
|
Antimicrob Agents Chemother
|
2014
|
2.18
|
|
4
|
An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009-10).
|
J Antimicrob Chemother
|
2011
|
2.03
|
|
5
|
Novel GES/IBC extended-spectrum beta-lactamase variants with carbapenemase activity in clinical enterobacteria.
|
FEMS Microbiol Lett
|
2004
|
1.99
|
|
6
|
An ertapenem-resistant extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant.
|
Antimicrob Agents Chemother
|
2010
|
1.40
|
|
7
|
Multilocus sequence typing of IncN plasmids.
|
J Antimicrob Chemother
|
2011
|
1.39
|
|
8
|
Emerging Klebsiella pneumoniae isolates coproducing KPC-2 and VIM-1 carbapenemases.
|
Antimicrob Agents Chemother
|
2009
|
1.17
|
|
9
|
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases.
|
Antimicrob Agents Chemother
|
2010
|
1.17
|
|
10
|
Emergence of Escherichia coli sequence type 410 (ST410) with KPC-2 β-lactamase.
|
Int J Antimicrob Agents
|
2012
|
1.16
|
|
11
|
Multidrug and broad-spectrum cephalosporin resistance among Salmonella enterica serotype enteritidis clinical isolates in southern Italy.
|
J Clin Microbiol
|
2002
|
1.14
|
|
12
|
Relative strengths of the class 1 integron promoter hybrid 2 and the combinations of strong and hybrid 1 with an active p2 promoter.
|
Antimicrob Agents Chemother
|
2008
|
1.12
|
|
13
|
Characterization of the IncA/C plasmid pCC416 encoding VIM-4 and CMY-4 beta-lactamases.
|
J Antimicrob Chemother
|
2007
|
1.05
|
|
14
|
Emergence of Klebsiella pneumoniae of a novel sequence type (ST383) producing VIM-4, KPC-2 and CMY-4 β-lactamases.
|
Int J Antimicrob Agents
|
2010
|
1.02
|
|
15
|
Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification.
|
BMC Infect Dis
|
2012
|
0.95
|
|
16
|
Detection of metallo-β-lactamase genes in clinical specimens by a commercial multiplex PCR system.
|
J Microbiol Methods
|
2010
|
0.94
|
|
17
|
Plasmid-encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli.
|
Antimicrob Agents Chemother
|
2007
|
0.93
|
|
18
|
Carbapenemase-producing Pseudomonas aeruginosa from central Greece: molecular epidemiology and genetic analysis of class I integrons.
|
BMC Infect Dis
|
2013
|
0.92
|
|
19
|
CMY-42, a novel plasmid-mediated CMY-2 variant AmpC beta-lactamase.
|
Microb Drug Resist
|
2011
|
0.90
|
|
20
|
Analysis of emergence of quinolone-resistant gonococci in Greece by combined use of Neisseria gonorrhoeae multiantigen sequence typing and multilocus sequence typing.
|
J Clin Microbiol
|
2011
|
0.90
|
|
21
|
Successful control of a neonatal outbreak caused mainly by ST20 multidrug-resistant SHV-5-producing Klebsiella pneumoniae, Greece.
|
BMC Pediatr
|
2014
|
0.89
|
|
22
|
Outbreak of Acinetobacter baumannii with chromosomally encoded VIM-1 undetectable by imipenem-EDTA synergy tests.
|
Antimicrob Agents Chemother
|
2008
|
0.86
|
|
23
|
Extended-spectrum properties of CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase.
|
Antimicrob Agents Chemother
|
2009
|
0.84
|
|
24
|
Cluster of multidrug-resistant Neisseria gonorrhoeae with reduced susceptibility to the newer cephalosporins in Northern Greece.
|
J Antimicrob Chemother
|
2008
|
0.84
|
|
25
|
Emergence of resistance to fosfomycin used as adjunct therapy in KPC Klebsiella pneumoniae bacteraemia: report of three cases.
|
J Antimicrob Chemother
|
2012
|
0.83
|
|
26
|
OmpK35 and OmpK36 porin variants associated with specific sequence types of Klebsiella pneumoniae.
|
J Chemother
|
2013
|
0.82
|
|
27
|
Interactions of oximino-substituted boronic acids and β-lactams with the CMY-2-derived extended-spectrum cephalosporinases CMY-30 and CMY-42.
|
Antimicrob Agents Chemother
|
2012
|
0.82
|
|
28
|
Effects of the Val211Gly substitution on molecular dynamics of the CMY-2 cephalosporinase: implications on hydrolysis of expanded-spectrum cephalosporins.
|
Proteins
|
2011
|
0.81
|
|
29
|
Emergence of NDM-producing Klebsiella pneumoniae in Greece.
|
Diagn Microbiol Infect Dis
|
2013
|
0.80
|
|
30
|
Changing figures of antimicrobial susceptibility and serovar distribution in Neisseria gonorrhoeae isolated in Greece.
|
Sex Transm Dis
|
2010
|
0.80
|
|
31
|
Antimicrobial susceptibility of Neisseria gonorrhoeae in Greece: data for the years 1994-2004.
|
J Antimicrob Chemother
|
2006
|
0.79
|
|
32
|
Comment on: Redefining extended-spectrum beta-lactamases: balancing science and clinical need.
|
J Antimicrob Chemother
|
2009
|
0.75
|
|
33
|
Characterisation of CTX-M-117, a Pro174Gln variant of CTX-M-15 extended-spectrum β-lactamase, from a bovine Escherichia coli isolate.
|
Int J Antimicrob Agents
|
2012
|
0.75
|